Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease

Clinical trial NCT00437125 · COMPLETED

Trial details

NCT number: NCT00437125
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Major Depressive Disorder Idiopathic Parkinson Disease

Start date: 2007-03-01
Primary completion: 2009-07-01
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.